TY  - CHAP
M1  - Book, Section
TI  - De Novo Glomerular DiseasesPosttransplantation
A1  - Jhaveri, Kenar D
A1  - Bijol, Vanesa
A1  - Seshan, Surya V
A2  - Molmenti, Ernesto Pompeo
PY  - 2023
T2  - Molmenti’s Kidney and Pancreas Transplantation: Operative Techniques and Medical Management, 2e
AB  - Novo  (new-onset)  glomerulonephritis  is  that  which  occurs  in  a  transplant  recipient  whose  original  kidney  disease  was  either  not  glomerular  or  was  of  a  different  pathological  type.  Typically  most  appear  a  year  or  later  after  the  kidney  transplantation.  De  novo  posttransplant  glomerular  diseases  have  the  same  pathological  features  as  native  diseases  of  the  respective  glomerular  type  when  fully  developed  or  sometimes  modified  by  the  ongoing  immunosuppressive  therapy.  This  may  occur  with  or  without  other  posttransplant  pathologic  findings  that  include  a  component  of  acute  or  chronic  rejection  or  an  infection.  Obtaining  information  about  the  original  renal  disease  is  useful  to  determine  de  novo  or  recurrent  status  of  the  glomerular  disease  in  the  renal  allograft.  The  most  common  de  novo  glomerular  diseases  are  membranous  glomerulopathy,  focal  segmental  glomerulosclerosis,  collapsing  glomerulopathy,  pediatric  donor-associated  size  mismatch  glomerulopathy,  anti-GBM  disease  in  Alport  syndrome  cases,  and  drug-induced  thrombotic  microangiopathy.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1194188147
ER  -